|
12 Nov, 2018 |
China National Medical Product Administration (NMPA) has revised the special approval procedures for innovative medical devices issued in 2014 to respond to current state. This revision will be effective on December 1, 2018.
After the detailed review and analysis, Qualtech has outlined ten major differences between the new and previous version of regulations, as below:
Reference: